Moxifloxacin Tablet, Film Coated
Product Images NDC 63629-8357

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 63629-8357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure)

Figure (Figure)
A pharmacokinetic curve showing plasma concentration (µg/mL) versus time (hours) for Moxifloxacin 400 mg administered orally and intravenously. The graph compares plasma concentration levels over a 24-hour period, with separate curves for oral dose and intravenous dose.*
FDA Label Image

Label (Lbl636298357)

Label (Lbl636298357)
Label for Moxifloxacin Hcl 400 mg tablet packaged by Bryant Ranch Prepack, Burbank, CA. The label compares to Avelox 400 mg tablet by Dr. Reddys Laboratories Limited. It includes storage instructions at 20°-25°C and a warning to keep drugs out of reach of children. The label shows NDC 63629-8357-1 and indicates Rx only.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of moxifloxacin hydrochloride, showing its molecular components and arrangement, from an FDA Structured Product Labeling submission.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.